PCSK9 inhibitors in a renal transplant patient complicated with hepatitis B: A case report and literature review

PCSK9 inhibitors in a renal transplant patient complicated with hepatitis B: A case report and literature review

Lipid metabolism disorders are recognized to be one of the most frequent complications of renal transplantation, while dyslipidemia and chronic kidney disease (CKD) are strong risk factors for arteriosclerotic cardiovascular disease (ASCVD). Proprotein convertase subtilisin/kexin type 9 inhibitors (...

Full description

Bibliographic Details
Main Authors: Pinchao Lv, Yuxi Li, Lin Wu, Haoyu Weng, Ming Chen, Wenhui Ding, Jianping Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
dyslipidemia
renal transplantation
viral hepatitis
PCSK9i
coronary heart disease
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.937474/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.937474/full

Similar Items